litlas
Log inCreate account

Robert L. Ferris

Active 1995–2026

262
Papers
47,254
Citations
113
h-index
251
i10-index

Citations

Citations per year for Robert L. Ferris1995: 2 citations1996: 1 citations1997: 3 citations1998: 1 citations1999: 1 citations2000: 6 citations2001: 4 citations2002: 2 citations2003: 6 citations2004: 7 citations2005: 38 citations2006: 58 citations2007: 66 citations2008: 78 citations2009: 69 citations2010: 102 citations2011: 100 citations2012: 110 citations2013: 194 citations2014: 195 citations2015: 307 citations2016: 346 citations2017: 582 citations2018: 549 citations2019: 1,991 citations2020: 2,440 citations2021: 2,549 citations2022: 2,078 citations2023: 1,655 citations2024: 2,453 citations2025: 1,247 citations2026: 35 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,227 citing papers, 26.8% of this breakdownChina: 3,174 citing papers, 16.3% of this breakdownItaly: 965 citing papers, 4.9% of this breakdownGermany: 908 citing papers, 4.7% of this breakdownUnited Kingdom: 824 citing papers, 4.2% of this breakdownFrance: 673 citing papers, 3.5% of this breakdownJapan: 669 citing papers, 3.4% of this breakdownCanada: 616 citing papers, 3.2% of this breakdownSpain: 488 citing papers, 2.5% of this breakdownNetherlands: 456 citing papers, 2.3% of this breakdownAustralia: 440 citing papers, 2.3% of this breakdownSouth Korea: 439 citing papers, 2.3% of this breakdown
0%26.8%Other 23.6%

Institutions

Fields

  • Medicine62.8%
  • Biochemistry, Genetics and Molecular Biology20.1%
  • Immunology and Microbiology13%
  • Engineering0.9%
  • Neuroscience0.6%
  • Dentistry0.5%
  • Other2.1%

Topics

  • Cancer Immunotherapy and Biomarkers9.8%
  • Head and Neck Cancer Studies6.2%
  • Immunotherapy and Immune Responses4.4%
  • Immune Cell Function and Interaction4.4%
  • Thyroid Cancer Diagnosis and Treatment3.4%
  • CAR-T cell therapy research2.9%
  • Other68.9%

Coauthors

All papers

Open in search
  1. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

    Authors: Robert L. Ferris, George R. Blumenschein, Jérôme Fayette, J. Guigay, A. Dimitrios Colevas, Lisa Licitra, Kevin J. Harrington, Stefan Kasper, Everett E. Vokes, Caroline Even, Francis P. Worden, Nabil F. Saba, Lara Carmen Iglesias Docampo, Robert I. Haddad, Tamara Rordorf, Naomi Kiyota, Makoto Tahara, Manish Monga, Mark Lynch, William J. Geese, Justin Kopit, James W. Shaw, Maura L. Gillison - New England Journal of Medicine 2016 cited by 5,078

  2. Integrated Genomic Characterization of Papillary Thyroid Carcinoma

    Authors: Nishant Agrawal, Rehan Akbani, Bülent Arman Aksoy, Adrian Ally, Harindra Arachchi, L. Sylvia, J. Todd Auman, Miruna Balasundaram, Saianand Balu, Stephen B. Baylin, Madhusmita Behera, Brady Bernard, Rameen Beroukhim, Justin A. Bishop, Aaron D. Black, Tom Bodenheimer, Lori Boice, Moiz S. Bootwalla, Jay Bowen, Reanne Bowlby, Christopher A. Bristow, Robin Brookens, Denise Brooks, Robert Bryant, Elizabeth Buda, Yaron S.N. Butterfield, Tobias Carling, Rebecca Carlsen, Scott L. Carter, Sally E. Carty, Timothy A. Chan, Amy Y. Chen, Andrew D. Cherniack, Dorothy Cheung, Lynda Chin, Juok Cho, Andy Chu, Eric Chuah, Kristian Cibulskis, Giovanni Ciriello, Amanda Clarke, Gary L. Clayman, Leslie Cope, John A. Copland, Kyle R. Covington, Ludmila Danilova, Tanja M. Davidsen, John A. Demchok, Daniel DiCara, Noreen Dhalla, Rajiv Dhir, Sheliann S. Dookran, Gideon Dresdner, Jonathan Eldridge, Greg Eley, Adel K. El‐Naggar, Stephanie Eng, James A. Fagin, Timothy R. Fennell, Robert L. Ferris, Sheila Fisher, Scott Frazer, Jessica Frick, Stacey Gabriel, Ian Ganly, Jianjiong Gao, Levi A. Garraway, Julie M. Gastier-Foster, Gad Getz, Nils Gehlenborg, Ronald Ghossein, Richard A. Gibbs, Thomas J. Giordano, Karen Gomez-Hernandez, Jonna Grimsby, Benjamin Groß, Ranabir Guin, Angela Hadjipanayis, Hollie A. Harper, D. Neil Hayes, David I. Heiman, James G. Herman, Katherine A. Hoadley, Matan Hofree, Robert A. Holt, Alan P. Hoyle, Franklin W. Huang, Mei Huang, Carolyn M. Hutter, Trey Ideker, Lisa Iype, Anders Jacobsen, Stuart R. Jefferys, Corbin D. Jones, Steven J.M. Jones, Katayoon Kasaian, Electron Kebebew, Fadlo R. Khuri, Jaegil Kim, Roger Kramer and 143 more - Cell 2014 cited by 3,126

  3. Head and neck cancer

    Authors: Athanassios Argiris, Michalis V. Karamouzis, David Raben, Robert L. Ferris - The Lancet 2008 cited by 2,220

  4. Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer

    Authors: Anthony R. Cillo, Cornelius Kürten, Tracy Tabib, Zengbiao Qi, Sayali Onkar, Ting Wang, Angen Liu, Umamaheswar Duvvuri, Seungwon Kim, Ryan J. Soose, Steffi Oesterreich, Wei Chen, Robert Lafyatis, Tullia C. Bruno, Robert L. Ferris, Dario A.A. Vignali - Immunity 2020 cited by 679

  5. Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

    Authors: Nancy Y. Lee, Robert L. Ferris, Amanda Psyrri, Robert I. Haddad, Makoto Tahara, Jean Bourhis, Kevin J. Harrington, Peter Mu‐Hsin Chang, Jin‐Ching Lin, Mohammad Razaq, Maria Margarida Teixeira, József Lövey, J. Chamois, Antonio Rueda, Chaosu Hu, Lara Dunn, Mikhail Dvorkin, Steven De Beukelaer, Dmitri Pavlov, Holger Thurm, Ezra E.W. Cohen - The Lancet Oncology 2021 cited by 617

  6. The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction

    Authors: Nicole E. Scharping, Ashley V. Menk, Rebecca S. Moreci, Ryan D. Whetstone, Rebekah Dadey, Simon C. Watkins, Robert L. Ferris, Greg M. Delgoffe - Immunity 2016 cited by 801

  7. Lipid accumulation and dendritic cell dysfunction in cancer

    Authors: Donna L. Herber, Wei Cao, Yulia Nefedova, Sergey V. Novitskiy, Srinivas Nagaraj, Vladimir A. Tyurin, Alex Corzo, Hyun-Il Cho, Esteban Celis, Brianna Lennox, Stella C. Knight, Tapan Padhya, Thomas V. McCaffrey, Judith C. McCaffrey, Scott Antonia, Mayer Fishman, Robert L. Ferris, Valerian E. Kagan, Dmitry I. Gabrilovich - Nature Medicine 2010 cited by 699

  8. B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma

    Authors: Ayana T. Ruffin, Anthony R. Cillo, Tracy Tabib, Angen Liu, Sayali Onkar, Sheryl Kunning, Caleb Lampenfeld, Huda I. Atiya, Irina Abécassis, Cornelius Kürten, Zengbiao Qi, Ryan J. Soose, Umamaheswar Duvvuri, Seungwon Kim, Steffi Oesterrich, Robert Lafyatis, Lan Coffman, Robert L. Ferris, Dario A.A. Vignali, Tullia C. Bruno - Nature Communications 2021 cited by 358

  9. The changing therapeutic landscape of head and neck cancer

    Authors: John D. Cramer, Barbara Burtness, Quynh‐Thu Le, Robert L. Ferris - Nature Reviews Clinical Oncology 2019 cited by 812

  10. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

    Authors: Ezra E.W. Cohen, R. Bryan Bell, Carlo Bifulco, Barbara Burtness, Maura L. Gillison, Kevin J. Harrington, Quynh‐Thu Le, Nancy Y. Lee, Rom S. Leidner, Rebecca Lewis, Lisa Licitra, Hisham Mehanna, Loren K. Mell, Adam Raben, Andrew G. Sikora, Ravindra Uppaluri, Fernanda Whitworth, Dan P. Zandberg, Robert L. Ferris - Journal for ImmunoTherapy of Cancer 2019 cited by 738

  11. Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity

    Authors: Abigail E. Overacre-Delgoffe, Maria Chikina, Rebekah Dadey, Hiroshi Yano, Erin A. Brunazzi, Gulidanna Shayan, William Horne, Jessica Moskovitz, Jay K. Kolls, Cindy Sander, Yongli Shuai, Daniel P. Normolle, John M. Kirkwood, Robert L. Ferris, Greg M. Delgoffe, Tullia C. Bruno, Creg J. Workman, Dario A.A. Vignali - Cell 2017 cited by 624

  12. Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing

    Authors: Cornelius Kürten, Aditi Kulkarni, Anthony R. Cillo, P.M.L. Santos, Anna K. Roble, Sayali Onkar, Carly Reeder, Stephan Lang, Xueer Chen, Umamaheswar Duvvuri, Seungwon Kim, Angen Liu, Tracy Tabib, Robert Lafyatis, Jian Feng, Shou‐Jiang Gao, Tullia C. Bruno, Dario A.A. Vignali, Xinghua Lu, Riyue Bao, Lazar Vujanović, Robert L. Ferris - Nature Communications 2021 cited by 293

  13. Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment

    Authors: Ayana T. Ruffin, Housaiyin Li, Lazar Vujanović, Dan P. Zandberg, Robert L. Ferris, Tullia C. Bruno - Nature reviews. Cancer 2022 cited by 290

  14. Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce

    Authors: Harriet M. Kluger, Hussein A. Tawbi, Maria Libera Ascierto, Michaela Bowden, Margaret K. Callahan, Edward Cha, Helen X. Chen, Charles G. Drake, David Feltquate, Robert L. Ferris, James L. Gulley, Shilpa Gupta, Rachel Humphrey, Theresa LaVallee, Dung T. Le, Vanessa M. Hubbard-Lucey, Vassiliki A. Papadimitrakopoulou, Michael A. Postow, Eric H. Rubin, Elad Sharon, Janis M. Taube, Suzanne L. Topalian, Roberta Zappasodi, Mario Sznol, Ryan J. Sullivan - Journal for ImmunoTherapy of Cancer 2020 cited by 280

  15. Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)

    Authors: Robert L. Ferris, Yael Flamand, Gregory S. Weinstein, Shuli Li, Harry Quon, Ranee Mehra, Joaquin J. Garcia, Christine H. Chung, Maura L. Gillison, Umamaheswar Duvvuri, Bert W. O'Malley, Enver Ozer, Giovana R. Thomas, Wayne M. Koch, Neil D. Gross, R. Bryan Bell, Nabil F. Saba, Miriam Lango, Eduardo Méndez, Barbara Burtness - Journal of Clinical Oncology 2021 cited by 441

  16. Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study

    Authors: Robert L. Ferris, Robert I. Haddad, Caroline Even, Makoto Tahara, Mikhail Dvorkin, Tudor–Eliade Ciuleanu, Paul M. Clément, Ricard Mesı́a, С. И. Кутукова, Lyubov Zholudeva, Amaury Daste, Javier Caballero-Daroqui, Bhumsuk Keam, Ihor Vynnychenko, C. Lafond, Jagdish Shetty, Helen Mann, Jean Fan, Sophie Wildsmith, Nassim Morsli, Jérôme Fayette, Lisa Licitra - Annals of Oncology 2020 cited by 365

  17. Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression

    Authors: Robert L. Ferris, George R. Blumenschein, Jérôme Fayette, J. Guigay, A. Dimitrios Colevas, Lisa Licitra, Kevin J. Harrington, Stefan Kasper, Everett E. Vokes, Caroline Even, Francis P. Worden, Nabil F. Saba, Lara Carmen Iglesias Docampo, Robert I. Haddad, Tamara Rordorf, Naomi Kiyota, Makoto Tahara, Mark Lynch, Vijayvel Jayaprakash, Li Li, Maura L. Gillison - Oral Oncology 2018 cited by 800

  18. Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial

    Authors: Robert L. Ferris, William C. Spanos, Rom S. Leidner, Anthony Gonçalvès, Uwe M. Martens, Chrisann Kyi, William H. Sharfman, Christine H. Chung, Lot A. Devriese, Hélène Gauthier, Simon I. Chiosea, Lazar Vujanović, Janis M. Taube, Julie E. Stein, Jun Li, Bin Li, Tian Chen, Adam Barrows, Suzanne L. Topalian - Journal for ImmunoTherapy of Cancer 2021 cited by 222

  19. Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651

    Authors: Robert I. Haddad, Kevin J. Harrington, Makoto Tahara, Robert L. Ferris, Maura L. Gillison, Jérôme Fayette, Amaury Daste, P. Koralewski, Bogdan Żurawski, Miren Taberna, Nabil F. Saba, Milena Perez Mak, Andrzej Kawecki, Gustavo Girotto, Miguel Ángel Álvarez-Avitia, Caroline Even, Joaquin Gabriel Reinoso Toledo, Alexander Guminski, Urs Müller‐Richter, Naomi Kiyota, Mustimbo Roberts, Tariq Aziz Khan, Karen Miller-Moslin, Wei Li, Athanassios Argiris - Journal of Clinical Oncology 2022 cited by 158

  20. Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial

    Authors: Charu Aggarwal, Amy Prawira, Scott Antonia, Osama E. Rahma, Anthony W. Tolcher, Roger B. Cohen, Yanyan Lou, Ralph J. Hauke, Nicholas J. Vogelzang, Dan P. Zandberg, Arash Rezazadeh Kalebasty, Victoria Atkinson, Alex A. Adjei, ­Mahesh Seetharam, Ariel E. Birnbaum, Andrew Weickhardt, Vinod Ganju, Anthony M. Joshua, Rosetta Cavallo, Linda Peng, Xiaoyu Zhang, Sanjeev Kaul, Jan Baughman, Ezio Bonvini, Paul A. Moore, S. Goldberg, Fernanda I. Arnaldez, Robert L. Ferris, Nehal J. Lakhani - Journal for ImmunoTherapy of Cancer 2022 cited by 141

  21. Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer

    Authors: Gulidanna Shayan, Raghvendra M. Srivastava, Jing Li, Nicole C. Schmitt, Larry Kane, Robert L. Ferris - OncoImmunology 2016 cited by 301

  22. Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology

    Authors: David L. Steward, Sally E. Carty, Rebecca S. Sippel, Samantha Peiling Yang, Julie Ann Sosa, Jennifer A. Sipos, James Figge, Susan J. Mandel, Bryan R. Haugen, Kenneth D. Burman, Zubair Baloch, Ricardo V. Lloyd, Raja R. Seethala, William E. Gooding, Simion I. Chiosea, Cristiane Gomes-Lima, Robert L. Ferris, Jessica M. Folek, Raheela Khawaja, Priya Kundra, Kwok Seng Loh, Carrie B. Marshall, Sarah E. Mayson, Kelly L. McCoy, Min En Nga, Kee Yuan Ngiam, Marina N. Nikiforova, Jennifer L. Poehls, Matthew D. Ringel, Huaitao Yang, Linwah Yip, Yuri E. Nikiforov - JAMA Oncology 2018 cited by 464

  23. Expression of Tim-3 drives phenotypic and functional changes in Treg cells in secondary lymphoid organs and the tumor microenvironment

    Authors: Hridesh Banerjee, Hector Nieves-Rosado, Aditi Kulkarni, Benjamin Murter, Kyle McGrath, Uma Chandran, Alexander Chang, Andrea L. Szymczak-Workman, Lazar Vujanović, Greg M. Delgoffe, Robert L. Ferris, Larry Kane - Cell Reports 2021 cited by 93

  24. Immunology and Immunotherapy of Head and Neck Cancer

    Authors: Robert L. Ferris - Journal of Clinical Oncology 2015 cited by 668